List of Tables
Table 1. Global Glucocorticoid Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Glucocorticoid Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Glucocorticoid Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Glucocorticoid Injection Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Glucocorticoid Injection Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Glucocorticoid Injection Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Glucocorticoid Injection Sales by Region (2020-2025) & (K Units)
Table 8. Global Glucocorticoid Injection Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Glucocorticoid Injection Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Glucocorticoid Injection Sales Share by Manufacturers (2020-2025)
Table 12. Global Glucocorticoid Injection Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Glucocorticoid Injection Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Glucocorticoid Injection by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucocorticoid Injection as of 2024)
Table 16. Global Glucocorticoid Injection Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Glucocorticoid Injection Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Glucocorticoid Injection Manufacturing Base and Headquarters
Table 19. Global Glucocorticoid Injection Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Glucocorticoid Injection Sales by Type (2020-2025) & (K Units)
Table 23. Global Glucocorticoid Injection Sales by Type (2026-2031) & (K Units)
Table 24. Global Glucocorticoid Injection Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Glucocorticoid Injection Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Glucocorticoid Injection ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Glucocorticoid Injection Sales by Application (2020-2025) & (K Units)
Table 29. Global Glucocorticoid Injection Sales by Application (2026-2031) & (K Units)
Table 30. Glucocorticoid Injection High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Glucocorticoid Injection Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Glucocorticoid Injection Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Glucocorticoid Injection ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Glucocorticoid Injection Growth Accelerators and Market Barriers
Table 37. North America Glucocorticoid Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Glucocorticoid Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Glucocorticoid Injection Growth Accelerators and Market Barriers
Table 40. Europe Glucocorticoid Injection Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Glucocorticoid Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Glucocorticoid Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Glucocorticoid Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Glucocorticoid Injection Growth Accelerators and Market Barriers
Table 45. Southeast Asia Glucocorticoid Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Glucocorticoid Injection Investment Opportunities and Key Challenges
Table 47. Central and South America Glucocorticoid Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Glucocorticoid Injection Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Glucocorticoid Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Pfizer Corporation Information
Table 51. Pfizer Description and Major Businesses
Table 52. Pfizer Product Models, Descriptions and Specifications
Table 53. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Pfizer Sales Value Proportion by Product in 2024
Table 55. Pfizer Sales Value Proportion by Application in 2024
Table 56. Pfizer Sales Value Proportion by Geographic Area in 2024
Table 57. Pfizer Glucocorticoid Injection SWOT Analysis
Table 58. Pfizer Recent Developments
Table 59. SiNi Pharma Corporation Information
Table 60. SiNi Pharma Description and Major Businesses
Table 61. SiNi Pharma Product Models, Descriptions and Specifications
Table 62. SiNi Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. SiNi Pharma Sales Value Proportion by Product in 2024
Table 64. SiNi Pharma Sales Value Proportion by Application in 2024
Table 65. SiNi Pharma Sales Value Proportion by Geographic Area in 2024
Table 66. SiNi Pharma Glucocorticoid Injection SWOT Analysis
Table 67. SiNi Pharma Recent Developments
Table 68. Wellona Pharma Corporation Information
Table 69. Wellona Pharma Description and Major Businesses
Table 70. Wellona Pharma Product Models, Descriptions and Specifications
Table 71. Wellona Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Wellona Pharma Sales Value Proportion by Product in 2024
Table 73. Wellona Pharma Sales Value Proportion by Application in 2024
Table 74. Wellona Pharma Sales Value Proportion by Geographic Area in 2024
Table 75. Wellona Pharma Glucocorticoid Injection SWOT Analysis
Table 76. Wellona Pharma Recent Developments
Table 77. AdvaCare Pharma Corporation Information
Table 78. AdvaCare Pharma Description and Major Businesses
Table 79. AdvaCare Pharma Product Models, Descriptions and Specifications
Table 80. AdvaCare Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. AdvaCare Pharma Sales Value Proportion by Product in 2024
Table 82. AdvaCare Pharma Sales Value Proportion by Application in 2024
Table 83. AdvaCare Pharma Sales Value Proportion by Geographic Area in 2024
Table 84. AdvaCare Pharma Glucocorticoid Injection SWOT Analysis
Table 85. AdvaCare Pharma Recent Developments
Table 86. Eurocrit Labs Corporation Information
Table 87. Eurocrit Labs Description and Major Businesses
Table 88. Eurocrit Labs Product Models, Descriptions and Specifications
Table 89. Eurocrit Labs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Eurocrit Labs Sales Value Proportion by Product in 2024
Table 91. Eurocrit Labs Sales Value Proportion by Application in 2024
Table 92. Eurocrit Labs Sales Value Proportion by Geographic Area in 2024
Table 93. Eurocrit Labs Glucocorticoid Injection SWOT Analysis
Table 94. Eurocrit Labs Recent Developments
Table 95. Pyxus Pharmaceutical Corporation Information
Table 96. Pyxus Pharmaceutical Description and Major Businesses
Table 97. Pyxus Pharmaceutical Product Models, Descriptions and Specifications
Table 98. Pyxus Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Pyxus Pharmaceutical Recent Developments
Table 100. Zydus Cadila Corporation Information
Table 101. Zydus Cadila Description and Major Businesses
Table 102. Zydus Cadila Product Models, Descriptions and Specifications
Table 103. Zydus Cadila Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Zydus Cadila Recent Developments
Table 105. Weefsel Pharma Corporation Information
Table 106. Weefsel Pharma Description and Major Businesses
Table 107. Weefsel Pharma Product Models, Descriptions and Specifications
Table 108. Weefsel Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Weefsel Pharma Recent Developments
Table 110. Taj Pharmaceuticals Limited Corporation Information
Table 111. Taj Pharmaceuticals Limited Description and Major Businesses
Table 112. Taj Pharmaceuticals Limited Product Models, Descriptions and Specifications
Table 113. Taj Pharmaceuticals Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Taj Pharmaceuticals Limited Recent Developments
Table 115. Caspian Tamin Pharmaceutical Company Corporation Information
Table 116. Caspian Tamin Pharmaceutical Company Description and Major Businesses
Table 117. Caspian Tamin Pharmaceutical Company Product Models, Descriptions and Specifications
Table 118. Caspian Tamin Pharmaceutical Company Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Caspian Tamin Pharmaceutical Company Recent Developments
Table 120. Cipla Ltd Corporation Information
Table 121. Cipla Ltd Description and Major Businesses
Table 122. Cipla Ltd Product Models, Descriptions and Specifications
Table 123. Cipla Ltd Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Cipla Ltd Recent Developments
Table 125. Nexphex Global Pharma Private Limited Corporation Information
Table 126. Nexphex Global Pharma Private Limited Description and Major Businesses
Table 127. Nexphex Global Pharma Private Limited Product Models, Descriptions and Specifications
Table 128. Nexphex Global Pharma Private Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Nexphex Global Pharma Private Limited Recent Developments
Table 130. Criticine Care Corporation Information
Table 131. Criticine Care Description and Major Businesses
Table 132. Criticine Care Product Models, Descriptions and Specifications
Table 133. Criticine Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Criticine Care Recent Developments
Table 135. Nephron Pharmaceuticals Corporation Information
Table 136. Nephron Pharmaceuticals Description and Major Businesses
Table 137. Nephron Pharmaceuticals Product Models, Descriptions and Specifications
Table 138. Nephron Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Nephron Pharmaceuticals Recent Developments
Table 140. Key Raw Materials Distribution
Table 141. Raw Materials Key Suppliers
Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 143. Milestones in Production Technology Evolution
Table 144. Distributors List
Table 145. Market Trends and Market Evolution
Table 146. Market Drivers and Opportunities
Table 147. Market Challenges, Risks, and Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucocorticoid Injection Product Picture
Figure 2. Global Glucocorticoid Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Beclomethasone Injection Product Picture
Figure 4. Betamethasone Injection Product Picture
Figure 5. Budesonide Injection Product Picture
Figure 6. Cortisone Injection Product Picture
Figure 7. Dexamethasone Injection Product Picture
Figure 8. Hydrocortisone Injection Product Picture
Figure 9. Methylprednisolone Injection Product Picture
Figure 10. Prednisolone Injection Product Picture
Figure 11. Global Glucocorticoid Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Rheumatoid Arthritis
Figure 13. Allergic Diseases
Figure 14. Bronchial Asthma
Figure 15. Autoimmune Disease
Figure 16. Skin Diseases
Figure 17. Others
Figure 18. Glucocorticoid Injection Report Years Considered
Figure 19. Global Glucocorticoid Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 21. Global Glucocorticoid Injection Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 22. Global Glucocorticoid Injection Revenue Market Share by Region (2020-2031)
Figure 23. Global Glucocorticoid Injection Sales (2020-2031) & (K Units)
Figure 24. Global Glucocorticoid Injection Sales (CAGR) by Region (2020-2031) (K Units)
Figure 25. Global Glucocorticoid Injection Sales Market Share by Region (2020-2031)
Figure 26. Top 5 and Top 10 Manufacturers Glucocorticoid Injection Sales Volume Market Share in 2024
Figure 27. Global Glucocorticoid Injection Revenue Market Share Ranking (2024)
Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 29. Beclomethasone Injection Revenue Market Share by Manufacturer in 2024
Figure 30. Betamethasone Injection Revenue Market Share by Manufacturer in 2024
Figure 31. Budesonide Injection Revenue Market Share by Manufacturer in 2024
Figure 32. Cortisone Injection Revenue Market Share by Manufacturer in 2024
Figure 33. Dexamethasone Injection Revenue Market Share by Manufacturer in 2024
Figure 34. Hydrocortisone Injection Revenue Market Share by Manufacturer in 2024
Figure 35. Methylprednisolone Injection Revenue Market Share by Manufacturer in 2024
Figure 36. Prednisolone Injection Revenue Market Share by Manufacturer in 2024
Figure 37. Global Glucocorticoid Injection Sales Market Share by Type (2020-2031)
Figure 38. Global Glucocorticoid Injection Revenue Market Share by Type (2020-2031)
Figure 39. Global Glucocorticoid Injection Sales Market Share by Application (2020-2031)
Figure 40. Global Glucocorticoid Injection Revenue Market Share by Application (2020-2031)
Figure 41. North America Glucocorticoid Injection Sales YoY (2020-2031) & (K Units)
Figure 42. North America Glucocorticoid Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 43. North America Top 5 Manufacturers Glucocorticoid Injection Sales Revenue (US$ Million) in 2024
Figure 44. North America Glucocorticoid Injection Sales Volume (K Units) by Type (2020- 2031)
Figure 45. North America Glucocorticoid Injection Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 46. North America Glucocorticoid Injection Sales Volume (K Units) by Application (2020-2031)
Figure 47. North America Glucocorticoid Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. US Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 49. Canada Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 50. Mexico Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 51. Europe Glucocorticoid Injection Sales YoY (2020-2031) & (K Units)
Figure 52. Europe Glucocorticoid Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Europe Top 5 Manufacturers Glucocorticoid Injection Sales Revenue (US$ Million) in 2024
Figure 54. Europe Glucocorticoid Injection Sales Volume (K Units) by Type (2020-2031)
Figure 55. Europe Glucocorticoid Injection Sales Revenue (US$ Million) by Type (2020-2031)
Figure 56. Europe Glucocorticoid Injection Sales Volume (K Units) by Application (2020-2031)
Figure 57. Europe Glucocorticoid Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 58. Germany Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 59. France Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 60. U.K. Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 61. Italy Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 62. Russia Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 63. Asia-Pacific Glucocorticoid Injection Sales YoY (2020-2031) & (K Units)
Figure 64. Asia-Pacific Glucocorticoid Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Asia-Pacific Top 8 Manufacturers Glucocorticoid Injection Sales Revenue (US$ Million) in 2024
Figure 66. Asia-Pacific Glucocorticoid Injection Sales Volume (K Units) by Type (2020- 2031)
Figure 67. Asia-Pacific Glucocorticoid Injection Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 68. Asia-Pacific Glucocorticoid Injection Sales Volume (K Units) by Application (2020-2031)
Figure 69. Asia-Pacific Glucocorticoid Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 70. Indonesia Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 71. Japan Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 72. South Korea Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 73. China Taiwan Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 74. India Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 75. Central and South America Glucocorticoid Injection Sales YoY (2020-2031) & (K Units)
Figure 76. Central and South America Glucocorticoid Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 77. Central and South America Top 5 Manufacturers Glucocorticoid Injection Sales Revenue (US$ Million) in 2024
Figure 78. Central and South America Glucocorticoid Injection Sales Volume (K Units) by Type (2021-2031)
Figure 79. Central and South America Glucocorticoid Injection Sales Revenue (US$ Million) by Type (2020-2031)
Figure 80. Central and South America Glucocorticoid Injection Sales Volume (K Units) by Application (2020-2031)
Figure 81. Central and South America Glucocorticoid Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 82. Brazil Glucocorticoid Injection Revenue (2020-2025) & (US$ Million)
Figure 83. Argentina Glucocorticoid Injection Revenue (2020-2025) & (US$ Million)
Figure 84. Middle East, and Africa Glucocorticoid Injection Sales YoY (2020-2031) & (K Units)
Figure 85. Middle East and Africa Glucocorticoid Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 86. Middle East and Africa Top 5 Manufacturers Glucocorticoid Injection Sales Revenue (US$ Million) in 2024
Figure 87. Middle East and Africa Glucocorticoid Injection Sales Volume (K Units) by Type (2021-2031)
Figure 88. South America Glucocorticoid Injection Sales Revenue (US$ Million) by Type (2020-2031)
Figure 89. Middle East and Africa Glucocorticoid Injection Sales Volume (K Units) by Application (2020-2031)
Figure 90. Middle East and Africa Glucocorticoid Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 91. GCC Countries Glucocorticoid Injection Revenue (2020-2025) & (US$ Million)
Figure 92. Turkey Glucocorticoid Injection Revenue (2020-2025) & (US$ Million)
Figure 93. Egypt Glucocorticoid Injection Revenue (2020-2025) & (US$ Million)
Figure 94. South Africa Glucocorticoid Injection Revenue (2020-2025) & (US$ Million)
Figure 95. Glucocorticoid Injection Industry Chain Mapping
Figure 96. Regional Glucocorticoid Injection Manufacturing Base Distribution (%)
Figure 97. Global Glucocorticoid Injection Production Market Share by Region (2020-2031)
Figure 98. Glucocorticoid Injection Production Process
Figure 99. Regional Glucocorticoid Injection Production Cost Structure
Figure 100. Channels of Distribution (Direct Vs Distribution)
Figure 101. Bottom-up and Top-down Approaches for This Report
Figure 102. Data Triangulation
Figure 103. Key Executives Interviewed
